Self-Oxygenating Microneedle Patches Enabled by Black Phosphorus Nanocomposites for Sequential Photothermal/Photodynamic Melanoma Therapy
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c14546 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Lin He und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, College of Biology, Key Laboratory for Bio-Nanotechnolog…. Hauptthemen laut MEDLINE: Photochemotherapy, Nanocomposites, Melanoma, Phosphorus. Die Arbeit nennt 68 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Melanoma is a highly aggressive skin cancer with limited therapeutic efficacy under conventional monotherapy. Synergistic photothermal/photodynamic therapy (PTT/PDT) offers a promising therapeutic strategy, yet its sequential application remains challenging due to inadequate transdermal drug delivery, tumor hypoxia, and insufficient spatiotemporal control. Herein, we proposed a self-oxygenating microneedle (MN) patch for sequential PTT/PDT of melanoma by loading multifunctional black phosphorus (BP) nanocomposites into a hyaluronic acid (HA) matrix. Specifically, the multifunctional BP nanocomposites, denoted as CaO2/BP@PDA, were rationally engineered on photothermally and photodynamically active BP nanosheets via the integration of oxygen-generating calcium peroxide (CaO2) and a protective layer of polydopamine (PDA). Under sequential near-infrared (NIR) irradiation at 808 nm and 660 nm, the CaO2/BP@PDA provided sustained oxygen generation and exhibited synergistic PTT/PDT effects, achieving a high photothermal conversion efficiency (η = 42.26%) and a ∼2-fold enhancement in PDT efficacy compared with bare BP. Furthermore, the MN platform could enable efficient transdermal delivery and intratumoral accumulation. In vivo evaluation in a mouse melanoma model demonstrated that the CaO2/BP@PDA MN patches, combined with self-oxygenation and controllable light irradiation, could induce mild photothermia and enhanced reactive oxygen species (ROS) generation, achieving ∼97% melanoma inhibition without evident systemic toxicity. Mechanistically, the programmable PTT/PDT mediated by the CaO2/BP@PDA MN patches could amplify stress signaling, and drive metabolic disruption and apoptotic activation, ultimately leading to melanoma cell death. With these features, the proposed MN patches demonstrated effective sequential PTT/PDT against melanoma, highlighting their potential for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, College of Biology, Key Laboratory for Bio-Nanotechnology and Molecule Engineering of Hunan Province, Hunan University, Changs…
ORCID-Profile: Kemin Wang, Xiaoxiao He
Förderung
- National Natural Science Foundation of China
Zitieren
APA
He, L., Zhou, Y., Chen, M., Qi, L., Zhang, M., Xie, S., Liu, L., Wu, Y., Wang, K., Liu, J., & He, X. (2026). Self-Oxygenating Microneedle Patches Enabled by Black Phosphorus Nanocomposites for Sequential Photothermal/Photodynamic Melanoma Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c14546
Vancouver
He L, Zhou Y, Chen M, Qi L, Zhang M, Xie S, et al. Self-Oxygenating Microneedle Patches Enabled by Black Phosphorus Nanocomposites for Sequential Photothermal/Photodynamic Melanoma Therapy. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c14546
BibTeX
@article{He2026,
author = {He, Lin and Zhou, Yan and Chen, Mingjian and Qi, Lanlin and Zhang, Min and Xie, Shunyuan and Liu, Lamei and Wu, Yuchen and Wang, Kemin and Liu, Jianbo and He, Xiaoxiao},
title = {Self-Oxygenating Microneedle Patches Enabled by Black Phosphorus Nanocomposites for Sequential Photothermal/Photodynamic Melanoma Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c14546}
}
EUVIMED